possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)
The FDA is warning about a possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept).
There are 30 reports of serious infections...including 6 deaths.
Enbrel works by binding tumor necrosis factor (TNF)...a protein that leads to joint pain and inflammation.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote